• Home

  • Documents

  • TM System data to expand your care team. Automatic Uploads....1 Serious High >250 mg/dL 97.5 %...
2
DOB: Feb 1, 2000 Diabetes: Type 1 Emma Weir (14 days) CGM Overlay May 7, 2018 - May 20, 2018 Take Control. Stay Informed. A simple glance to track trends in your diabetes care and effortlessly share your Omnipod DASH TM System data to expand your care team. Automatic Uploads. Featured on the Omnipod DASH TM System. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Password ProConnect Code Username (Email) Effective Date: 29JUN2020, ECO-000686

TM System data to expand your care team. Automatic Uploads....1 Serious High >250 mg/dL 97.5 % Time CGM Active Glucose Target Range (70 - 180 mg/dL) Monday Tuesday Wednesday Thursday

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: TM System data to expand your care team. Automatic Uploads....1 Serious High >250 mg/dL 97.5 % Time CGM Active Glucose Target Range (70 - 180 mg/dL) Monday Tuesday Wednesday Thursday

GLUCOSE (CGM)

124 mg/dL

Average

41 mg/dL

Standard Deviation

32.8%

Coefficient of

Variation

1%

Serious Low

<54 mg/dL

4%

Low

<70 mg/dL

87%

In Target Range

70-180 mg/dL

9%

High

>180 mg/dL

1%

Serious High

>250 mg/dL

97.5%

% Time CGM Active

Glucose

Target Range (70 - 180 mg/dL)

Monday

Tuesday

Wednesday

Thursday

Friday

Saturday

Sunday

Percentiles

25 - 75%

10 - 90%

Median

Lowest - Highest

12 AM 3 6 AM 9 12 PM 3 6 PM 9 12 AM

Glucose(mg/dL) 400

300

200

100

0

Glucose(mg/dL) 400

300

200

100

0

DOB: Feb 1, 2000 Diabetes: Type 1

Emma Weir

(14 days)

CGM Overlay

May 7, 2018 - May 20, 2018

Confidential – Glooko © Copyright2018 Learn more at www.glooko.com 2/2

Take Control. Stay Informed. A simple glance to track trends in your diabetes care and effortlessly share your

Omnipod DASHTM System data to expand your care team.

Automatic Uploads. Featured on the Omnipod DASHTM System.

The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof.

Password ProConnect Code

Username (Email)

Effective Date: 29JUN2020, ECO-000686

Page 2: TM System data to expand your care team. Automatic Uploads....1 Serious High >250 mg/dL 97.5 % Time CGM Active Glucose Target Range (70 - 180 mg/dL) Monday Tuesday Wednesday Thursday

If you are experiencing any issues with Glooko,

please contact Glooko Support:Call: 1-800-206-6601 Text: 650-720-5310 Email: [email protected]

For more information on the Omnipod DASHTM System, contact the Insulet Customer Care Team:

Call: 1-800.591.3455 Visit: www.myomnipod.com

© 2020 Insulet Corporation. Omnipod, the Omnipod logo, DASH, the DASH logo, Podder and PodderCentral are trademarks or registered trademarks of Insulet Corporation. All rights reserved. Glooko is a trademark of Glooko, Inc. and used with permission. Insulet Corporation does not operate myglooko.com and is not responsible for its conduct or content. Visit www.glooko.com/privacy/ or call 800.206.6601 for more information. 40238-USA-ENG-AW_002_01

Create your Glooko Account:

Navigate to my.glooko.com

Log in or click Sign Up for Glooko Here and fill out your information• Enter a ProConnect Code to

automatically share your Omnipod DASHTM System data with your healthcare provider

Select I am an Omnipod® System user

PLEASE NOTE: If your doctor has uploaded your current Omnipod® PDM to Glooko before, you already have a Glooko account. If you can’t remember your login credentials, call Glooko Support at 1-800-206-6601. They’ll provide it to you and ensure that your account is connected to your doctor’s.

Enable automatic upload:

Navigate to settings and select Connect to DASHTM Cloud

1

Log in to PodderCentralTM2

Follow the on-screen prompts3

You are all set!

DON'T FORGET TO: • Add the ProConnect code so your physician

can view your data.• Make sure that your Wi-Fi on the PDM is

turned on.

1

2

3

Effective Date: 29JUN2020, ECO-000686


Clinical Policy: Evolocumab (Repatha)...a) ≥ 190 mg/dL for genetically mediated primary hyperlipidemias; b) ≥ 220 mg/dL for non-genetically mediated primary hyperlipidemias; b

Clinical Policy: Evolocumab (Repatha)...a) ≥ 190 mg/dL for genetically mediated primary hyperlipidemias; b) ≥ 220 mg/dL for non-genetically mediated primary hyperlipidemias; b

Documents
Diabetes Management in the Outpatient Setting. Diagnostic Criteria (before 2010) FPG≥126 mg/dl. Prediabetes (IFG)≥100 mg/dl. 75 gram OGTT 2 hour-value≥200

Diabetes Management in the Outpatient Setting. Diagnostic Criteria (before 2010) FPG≥126 mg/dl. Prediabetes (IFG)≥100 mg/dl. 75 gram OGTT 2 hour-value≥200

Documents
YAKLAŞIM - sbuichastaliklarikongresi.orgsbuichastaliklarikongresi.org/Sunumlar/SavasOzturk.pdf · Increase in serum creatinine by >0.5 mg/dL to >4.0 mg/dL OR. UO

YAKLAŞIM - sbuichastaliklarikongresi.orgsbuichastaliklarikongresi.org/Sunumlar/SavasOzturk.pdf · Increase in serum creatinine by >0.5 mg/dL to >4.0 mg/dL OR. UO

Documents
ilovepdf merged - CVポート · CBC MRI WBC Pit x 103/mm3 g/dL x 104/mm3 Alb BUN Cre Na/K/Cl CRP g/mL g/dL mg/dL mg/dL mEq/L mg/dL PT(sec) PT(INR) APT T sec sec D It IC & 3-0

ilovepdf merged - CVポート · CBC MRI WBC Pit x 103/mm3 g/dL x 104/mm3 Alb BUN Cre Na/K/Cl CRP g/mL g/dL mg/dL mg/dL mEq/L mg/dL PT(sec) PT(INR) APT T sec sec D It IC & 3-0

Documents
Serum Vitamin C (mg/dl) by Salad Intake

Serum Vitamin C (mg/dl) by Salad Intake

Documents
Fatal Brain Edema After Contrast-Agent Overdosemm3 (4,000-1 0,000), urea nitrogen (BUN) 22 mg/dl (8-20), creatinine 1.9 mg/dl (0.5-1.0), and uric acid > 12 mg/dl (2.7-7.8). Bilirubin

Fatal Brain Edema After Contrast-Agent Overdosemm3 (4,000-1 0,000), urea nitrogen (BUN) 22 mg/dl (8-20), creatinine 1.9 mg/dl (0.5-1.0), and uric acid > 12 mg/dl (2.7-7.8). Bilirubin

Documents
Prognostic value of morphologic and morphometric analyses ...creatinine level, (reference range obtained by our clinical laboratory: males=0.66–1.25 mg/dl, females=0.52– 1.04 mg/dl),

Prognostic value of morphologic and morphometric analyses ...creatinine level, (reference range obtained by our clinical laboratory: males=0.66–1.25 mg/dl, females=0.52– 1.04 mg/dl),

Documents
PowerPoint - 4x3 Arial NLA May 16 2019.pdfLDL-C reduction calculated 82 mg/dL 56 mg/dL 57 mg/dL Estimated 5 year MACE RRR1 44% 30% 31%. Title: PowerPoint - 4x3 Arial Author: Peter

PowerPoint - 4x3 Arial NLA May 16 2019.pdfLDL-C reduction calculated 82 mg/dL 56 mg/dL 57 mg/dL Estimated 5 year MACE RRR1 44% 30% 31%. Title: PowerPoint - 4x3 Arial Author: Peter

Documents
ucm 307467.pdfReference #2 - Script Your Future · Sunday Blood Glucose Time: _____ MG/DL:_____ Time: _____ MG/DL:_____ Time: _____ MG/DL:_____

ucm 307467.pdfReference #2 - Script Your Future · Sunday Blood Glucose Time: _____ MG/DL:_____ Time: _____ MG/DL:_____ Time: _____ MG/DL:_____

Documents
Monobind Inc. - Products · Phosphorus Uric Acid Alkaline Phosphatase LDH SGOT/AST Billirubin, Total SGPT/ALT GGTP Total Protein Albumin Globulin 4.4 mg/dL 1.5 mg/dL

Monobind Inc. - Products · Phosphorus Uric Acid Alkaline Phosphatase LDH SGOT/AST Billirubin, Total SGPT/ALT GGTP Total Protein Albumin Globulin 4.4 mg/dL 1.5 mg/dL

Documents
Case Report A Whole-Food Plant-Based Diet Reversed Angina ...downloads.hindawi.com/journals/cric/2015/978906.pdf · Total cholesterol (mg/dL) Triglycerides (mg/dL) HDLc (mg/dL)

Case Report A Whole-Food Plant-Based Diet Reversed Angina ...downloads.hindawi.com/journals/cric/2015/978906.pdf · Total cholesterol (mg/dL) Triglycerides (mg/dL) HDLc (mg/dL)

Documents
 · CBC WBC RBC Hb ESR alb. chol. TG BUN 4.6g/dl 2.5g/dl 291 mg/ dl 306 mg 20mg/dl ... 199'2-ËF proliferation < -C, matrix Y IgA silent acute purpura purpura

 · CBC WBC RBC Hb ESR alb. chol. TG BUN 4.6g/dl 2.5g/dl 291 mg/ dl 306 mg 20mg/dl ... 199'2-ËF proliferation < -C, matrix Y IgA silent acute purpura purpura

Documents
Managing Hyperglycemia in Acute Care · • Initiate insulin starting at ≤180 mg/dL • Once insulin started, 140-180 mg/dL recommended glucose range for most patients • More

Managing Hyperglycemia in Acute Care · • Initiate insulin starting at ≤180 mg/dL • Once insulin started, 140-180 mg/dL recommended glucose range for most patients • More

Documents
The normal blood glucose level during fasting is (a) 70 to 110 mg/dl (b) 80 to 200 mg/dl (c) 100 to 150 mg/dl (d) 200 to 250 mg/dl During emulsification,the bile salts convert bigger

The normal blood glucose level during fasting is (a) 70 to 110 mg/dl (b) 80 to 200 mg/dl (c) 100 to 150 mg/dl (d) 200 to 250 mg/dl During emulsification,the bile salts convert bigger

Documents
f01.justanswer.com · Bab Results 526 g/dL g/dL 2.6 g/dL 1.2 27 IU/L 32 IU/L 27 IU/L 2 0.1 mg/dL 36 mg/dL 14 mg/dL 149 mg!dL 9.0 mg/dL 21 mEq/L 149 mEq/L 4.1 mEq/L 36 113 mEq/L 111

f01.justanswer.com · Bab Results 526 g/dL g/dL 2.6 g/dL 1.2 27 IU/L 32 IU/L 27 IU/L 2 0.1 mg/dL 36 mg/dL 14 mg/dL 149 mg!dL 9.0 mg/dL 21 mEq/L 149 mEq/L 4.1 mEq/L 36 113 mEq/L 111

Documents
Scholar Varun Desale Desale.pdfCriteria for selection of patients: Patients having fasting blood sugar level ≥126 mg/dl or 2 hr plasma glucose level ≥200 mg/dl up to 600 mg /dl

Scholar Varun Desale Desale.pdfCriteria for selection of patients: Patients having fasting blood sugar level ≥126 mg/dl or 2 hr plasma glucose level ≥200 mg/dl up to 600 mg /dl

Documents
Clinical Policy: Alirocumab (Praluent) · a) ≥ 190 mg/dL for genetically mediated primary hyperlipidemias; b) ≥ 220 mg/dL for non-genetically mediated primary hyperlipidemias;

Clinical Policy: Alirocumab (Praluent) · a) ≥ 190 mg/dL for genetically mediated primary hyperlipidemias; b) ≥ 220 mg/dL for non-genetically mediated primary hyperlipidemias;

Documents
boehringer-ingelheim.jpFMtest 6.5 mg/dl 334 mg/dl 92 mg/dl 36 mg/dl 42.3 mg/ dl 70.8 % % 361 mg/ dl 383 ng/ml WBC 12800 /mm3 (stab 3. seg Iy Ht Alb T-cho BUN T-Bil GOT GPT I-DH ALP

boehringer-ingelheim.jpFMtest 6.5 mg/dl 334 mg/dl 92 mg/dl 36 mg/dl 42.3 mg/ dl 70.8 % % 361 mg/ dl 383 ng/ml WBC 12800 /mm3 (stab 3. seg Iy Ht Alb T-cho BUN T-Bil GOT GPT I-DH ALP

Documents
CLINICAL WORKSHEET #1 Cancer and Trauma · Class Lecture Notes from any NDFS course ... Hct 32% Glucose 105 mg/dl Albumin 2.7 g/dl Calcium 7.6 mg/dl JQ has never had any previous

CLINICAL WORKSHEET #1 Cancer and Trauma · Class Lecture Notes from any NDFS course ... Hct 32% Glucose 105 mg/dl Albumin 2.7 g/dl Calcium 7.6 mg/dl JQ has never had any previous

Documents
院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg

院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg

Documents
Vitamaze Garcinia Etikett 210x80 20190315 · Garcinia Cambogia Extrakt/Extract 10:1 632,00 mg 2528,00 mg / davo/thereof: HCAn 379,20 mg 1516,80 mg / DL-Choline Bitartrate 68,29 mg

Vitamaze Garcinia Etikett 210x80 20190315 · Garcinia Cambogia Extrakt/Extract 10:1 632,00 mg 2528,00 mg / davo/thereof: HCAn 379,20 mg 1516,80 mg / DL-Choline Bitartrate 68,29 mg

Documents
Pathophysiology of Hypertrophic Pyloric Stenosis Revisited ... · 2] = 0.45 × BL [cm]/creatinine [mg/dl] (creatinine [mg/dl] = µmol/l/88.4). 2.1. Limits The presented study has

Pathophysiology of Hypertrophic Pyloric Stenosis Revisited ... · 2] = 0.45 × BL [cm]/creatinine [mg/dl] (creatinine [mg/dl] = µmol/l/88.4). 2.1. Limits The presented study has

Documents
Cellular Uptake of Glucose. –80-110 mg/dl euglycemia –< 45 mg/dl hypoglycemia –> 150-200 mg/dlafter CHO meal (ie, below T max ) –> 300-600 mg/dluncontrolled

Cellular Uptake of Glucose. –80-110 mg/dl euglycemia –< 45 mg/dl hypoglycemia –> 150-200 mg/dlafter CHO meal (ie, below T max ) –> 300-600 mg/dluncontrolled

Documents
UvA-DARE (Digital Academic Repository) Genetic and ... · Totall cholesterol , mg/dl LDLL cholesterol , mg/dl HDLL cholesterol , mg/dl Triglycerides,, mg/dl Systolicc blood pressure,

UvA-DARE (Digital Academic Repository) Genetic and ... · Totall cholesterol , mg/dl LDLL cholesterol , mg/dl HDLL cholesterol , mg/dl Triglycerides,, mg/dl Systolicc blood pressure,

Documents
Meningitis/Encephalitis Panel · • LP – CSF is clear, colorless, 2 nucleated cells/µL, 2 RBCs/µL, glucose 85 mg/dL (serum 144 mg/dL), protein 102 mg/dL. HHV-6B causes roseola,

Meningitis/Encephalitis Panel · • LP – CSF is clear, colorless, 2 nucleated cells/µL, 2 RBCs/µL, glucose 85 mg/dL (serum 144 mg/dL), protein 102 mg/dL. HHV-6B causes roseola,

Documents
Alpha 1-antitrypsin deficiency and common variable ... · CHEST, 81: 1, JANUARY, 1982 ALPHA, ANTITRYPSIN DEFICIENCY 113 Tab le 1-Pa inily History IgG, mg/dl IgA, mg/dl 1gM, mg/dl

Alpha 1-antitrypsin deficiency and common variable ... · CHEST, 81: 1, JANUARY, 1982 ALPHA, ANTITRYPSIN DEFICIENCY 113 Tab le 1-Pa inily History IgG, mg/dl IgA, mg/dl 1gM, mg/dl

Documents
HYPOCALCEMIA. Difinition Ionized calcium 4.5 mg/dL; total calcium 8.5 mg/dL if serum protein is normal

HYPOCALCEMIA. Difinition Ionized calcium 4.5 mg/dL; total calcium 8.5 mg/dL if serum protein is normal

Documents
Achieving New Treatment Goals for LDL-C: Strategies for ... · 2 3 4 Atorvastatin Placebo 132 mg/dL 126 mg/dL 89 mg/dL Moderate Risk Lower LDL-C ↓CV Events 3% Placebo 1.9% Treatment

Achieving New Treatment Goals for LDL-C: Strategies for ... · 2 3 4 Atorvastatin Placebo 132 mg/dL 126 mg/dL 89 mg/dL Moderate Risk Lower LDL-C ↓CV Events 3% Placebo 1.9% Treatment

Documents
CK-MB - Wiener lab...867022324 / 00 p. 2/12 interferencias por bilirrubina hasta 390 mg/l (39 mg/dl), triglicéridos hasta 3,0 g/l (300 mg/dl) ni hemoglobina hasta 0,06 g/dl (60 mg/dl)

CK-MB - Wiener lab...867022324 / 00 p. 2/12 interferencias por bilirrubina hasta 390 mg/l (39 mg/dl), triglicéridos hasta 3,0 g/l (300 mg/dl) ni hemoglobina hasta 0,06 g/dl (60 mg/dl)

Documents
NUOVA NOTA 13 ALGORITMO APPLICATIVO. mg/dL cholesterol = mmol/L × 38.6 mg/dL triglycerides = mmol/L × 88.5 mg/dL glucose = mmol/L × 18 Particolari categorie

NUOVA NOTA 13 ALGORITMO APPLICATIVO. mg/dL cholesterol = mmol/L × 38.6 mg/dL triglycerides = mmol/L × 88.5 mg/dL glucose = mmol/L × 18 Particolari categorie

Documents